Cyproheptadine and Chlorpromazine Effects on Spasticity
Phase 3 Study of Cyproheptadine and Chlorpromazine Effects on Spasticity After Spinal Cord Injury
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada, T6G2R3
- University of Alberta
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Patients must have suffered a trauma to the spinal cord at least 6 months ago or longer. In addition, subjects must exhibit some degree of spasticity as determined by having an Ashworth Spasticity Score, as assessed by a physical therapist, greater than 1.
Exclusion Criteria:
- If patients have damage to the nervous system other than to the spinal cord
- Pregnant women
- Elderly Patients and debilitated patients
- Alcoholic Patients
Patients with:
- Known or suspected allergy to the medication or its ingredients
- Cardiovascular disease
- Hypotension
- Coronary artery disease
- Reduced liver or kidney function
- Comatose or depressed states due to CNS depressants
- Blood dyscrasias
- Bone marrow depression
- History of seizures
- Respiratory problems
- Hypocalcemia
- Monoamine oxidase inhibitor therapy
- Angle-closure glaucoma
- Stenosing peptic ulcer
- Symptomatic prostatic hypertrophy
- Bladder neck obstruction
- Pyloroduodenal obstruction
- History of bronchial asthma
- Increased intraocular pressure
- Hyperthyroidism
- Cardiovascular disease
- Hypertension
Patients taking:
- Amphetamines
- Antihistamines-second generation
- Anticonvulsants
- Anticholinergics
- CNS depressants
- Antidepressants
- Hypotensive agents
- Levodopa
- Lithium
Study Plan
How is the study designed?
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Complete Spinal Cord Injured Subjects
Patients with no motor scores in their legs and suffering a complete spinal cord injury.
|
|
Incomplete Spinal Cord Injured Subjects
Patient with some motor preservation below the injury and suffering an incomplete spinal cord injury.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cutaneomuscular Reflex Responses
Time Frame: Change after drug intake at baseline, 30minutes, 60minutes, 90minutes and 120minutes
|
Tibialis anterior reflex responses evoked by stimulation of the medial arch of the foot will be measured before and after drug administration.
|
Change after drug intake at baseline, 30minutes, 60minutes, 90minutes and 120minutes
|
|
Paired motor unit recordings
Time Frame: Change at baseline and 30, 60, 90 and 120min after drug intake
|
We obtain paired motor unit recordings to determine changes in neuronal excitability after drug intake in incomplete spinal-cord injured subjects only.
|
Change at baseline and 30, 60, 90 and 120min after drug intake
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure and Heart rate
Time Frame: Change at baseline and 30, 60, 90, 120 minutes after drug intake
|
We measure blood pressure and heart rate to determine the safety of the drug during the experiment and whether we can continue safely.
|
Change at baseline and 30, 60, 90, 120 minutes after drug intake
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Monica A Gorassini, PhD, University of Alberta
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Pro00020682
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.